Skip to main content
. 2016 Jun 8;44(4):855–864. doi: 10.1177/0300060516647550

Figure 4.

Figure 4.

Representative light photomicrographs of cell invasion (transwell assay) in the gastric adenocarcinoma cell line AGS following erlotinib treatment and/or transfection with small hairpin (sh)RNA targeting focal adhesion kinase (FAK). Group A, control group (nontransfected, no erlotinib); Group B, empty vector group (transfected with empty vector, no erlotinib); Group C, FAK group (transfected with FAK-shRNA, no erlotinib); Group D, erlotinib group (nontransfected, 40 µmol/l erlotinib); Group E, combination group (transfected with FAK-shRNA, 40 µmol/l erlotinib). Original magnification × 400.